Latest news with #ChristopherThomas
Yahoo
21-07-2025
- General
- Yahoo
Say a huge welcome to baby Amelia
Here is another baby recently born in Gwent. Every week on our New Arrivals page we give little ones a big welcome to the world. If you've recently had a baby and would like to share your news with us go to and fill in our easy-to-use Q&A. Amelia Rose Thomas was born on June 12, 2025, at the Grange University Hospital, near Cwmbran, weighing 8lb 9oz. Her parents are Christopher and Nicola Thomas, of Newport, and her big brother is Teddy Thomas, 23 months.
Daily Mirror
22-06-2025
- Daily Mirror
'I thought I was happily married, then Alexa tore my world apart'
A UK private investigator has revealed how he uses smart speakers like Alexa to catch out cheating partners - and the voice logs told one woman everything she needed to know Smart assistants like Amazon Alexa, Siri, and Google Home are not just for playing music or turning down the lights – they're becoming the unexpected sleuths in our homes. A UK private investigator has suggested that these clever gadgets could be unwitting detectives after working on a case where a woman discovered her husband was cheating. Christopher Thomas, from UK Private Investigators, said: "While the internet has made cheating easier in my opinion, smart devices are levelling the playing field. "These devices record so much information and many log what has been said or requested." A client grew suspicious after spotting odd voice commands and song requests on their shared Alexa history, according to Christopher. "She wasn't snooping," he clarified. "She was just trying to re-play a song she'd heard earlier. But when she opened the Alexa app, she found a string of romantic song requests, followed by a dinner recipe, and then mood lighting being set, all while she was at work." Initially, she thought it might be a system error or an accidental repeat of an old command. "When she confronted her partner, he claimed he must have hit the wrong button on the app remotely. But the voice logs told a different story," Christopher revealed. "The voice commands had been recorded and saved. It wasn't him and it definitely wasn't her." The commands included "play a romantic playlist, set dining lights to 40%," and advice on "how to cook duck confit." The digital forensics expert says that smart technology is increasingly playing the role of detective in infidelity cases, as people often overlook how extensively they're monitored. "These devices track everything including the exact words used, the time of day, even who said what. You might delete your texts, but smart assistants keep a record of your day." Christopher points out that discovering deceit in relationships often comes down to piecing together the subtle clues rather than cinematic confrontations. "In the real world, it's about gathering breadcrumbs that reveal the full story." He warns that while smart devices offer convenience, they also document interactions with undeniable clarity. "Alexa doesn't lie," he remarked, signalling that a smart speaker may be privy to more secrets than one imagines when it comes to unfaithful partners. It comes after one man admitted to sleeping with his brother's wife after a drunken night out. Speaking to agony aunt Coleen Nolan, the unamed man revealed that he's 'eaten up with guilt' after the drunken, one-off encounter. He said: "I got chatting to my sister-in-law about life and then we moved on to discussing my brother and she admitted that she's fallen out of love with him. The conversation got really deep and personal, and sparks started to fly. Unfortunately, one thing led to another and I ended up in bed with her." The brother asked Coleen whether or not he should come clean. She responded: "To be completely honest, I think if you tell your brother, your relationship is as good as over. Ask yourself what your motive is for telling him – is it just about you and getting rid of your guilt by handing the problem to him? "It is hard to live with guilt, but sometimes when you've made a bad choice, you have to. I guess there's a chance his wife will pursue a divorce, as it's clear the marriage is in trouble and she's admitted she's not in love with him, so your problem might go away. You could leave it and pray it never comes out – the danger is, if your brother and his wife get into an argument and she wants to hurt him, she might blurt out that she slept with you. "So, the next question is, can you trust her? It's less important for her to keep what happened a secret because she can walk away and move on, but your relationship with your brother will be left in ruins. "You say you've never spoken to her about that night, but maybe it would be a good idea to have a conversation during a break at work about how you handle things going forward. It might make things less awkward when you have to see each other with the rest of the family and provide some sort of reassurance."
Yahoo
12-06-2025
- Health
- Yahoo
Cytovale's Rapid Diagnostic Slashes Sepsis Mortality by 39%, Peer-Reviewed Study Confirms
Cytovale's IntelliSep® sepsis test highlights a new model for ED triage that's already delivering systemwide clinical and economic value Results of real-world study with 12,000+ patients published in the journal Healthcare SAN FRANCISCO, June 12, 2025 /PRNewswire/ -- One of the largest real-world studies of a sepsis diagnostic reveals that Cytovale's IntelliSep®, a U.S. Food and Drug Administration (FDA)-cleared rapid host response diagnostic, reduced the relative rate of sepsis mortality by 39%, shortened length of hospital stay and enabled more efficient resource allocation in the emergency department (ED). The study, "Impact of a Sepsis Quality Improvement Initiative on Clinical and Operational Outcomes," published in the peer-reviewed journal Healthcare, followed more than 12,000 patients over 12 months at Our Lady of the Lake Regional Medical Center (OLOLRMC), a 900-bed in-patient acute care facility and Level 1 trauma center in Baton Rouge, La. "This is the kind of data the medical field has been waiting for and the results represent a breakthrough in sepsis care," said Dr. Christopher Thomas, study author who serves as Vice President and Chief Quality Officer at Franciscan Missionaries of Our Lady Health System (FMOLHS) and is a critical care physician at Louisiana State University Health Sciences Center. "With this small operational change, we are able to save more lives, deliver better care faster and optimize use of hospital resources. It's a pivotal step forward in how emergency departments manage sepsis. With IntelliSep, we've discovered a new way to save lives." Key Study Findings 39% relative rate reduction in sepsis mortality, with non-sepsis mortality unchanged, validating the impact of IntelliSep on targeted triage. 0.76 day decrease in average hospital length of stay for sepsis patients, with strong implications for improved throughput and cost reduction. 40% decrease in blood culture usage in low risk patients and an 8% increase in high-risk cases, underscoring the ability of IntelliSep to help providers fine-tune diagnostic precision. Detecting Sepsis in Minutes, Bringing Speed and Confidence to the FrontlineSepsis is one of the most elusive and deadly conditions in modern medicine, responsible for nearly one in three hospital deaths in the United States. EDs often err on the side of caution, treating a wide range of incoming patients as potentially septic because there is a lack of reliable, objective methods for early risk assessment. Treating every patient as potentially septic, while understandable in a high-stakes environment like the ED, often results in unnecessary, non-beneficial interventions for patients who likely do not have sepsis. The strains on limited ED resources was a top concern for OLOLRMC when it implemented IntelliSep as part of a nurse-driven sepsis triage initiative designed to identify and rapidly triage patients at highest risk. IntelliSep is the first and only FDA-cleared diagnostic to aid in early sepsis detection in the ED. Using a routine blood draw, the test delivers results in about eight minutes. This helps clinicians to rule in or rule out sepsis even before clinical signs are fully visible, giving them greater confidence to determine which patients are in most urgent need of care. The combination of a rapid diagnostic and a protocolized workflow has yielded what the study authors describe as a "game-changing model" for health systems nationwide. "This is more than an innovation – it's a paradigm shift in how health systems are managing sepsis," said Dr. Hollis O'Neal, Medical Director of Research at OLOLRMC. "For decades, sepsis mortality rates have remained stagnant because we've lacked a fast, reliable way to catch sepsis early. This study proves that with speed, objectivity and accuracy at the point of triage, we can change outcomes before antibiotics are given or ICU beds are needed. That's where real transformation begins." Validated in One Hospital, Scaled Across the Health SystemSepsis is not just a clinical challenge, it's a financial one. For hospitals with more than 500 beds, annual sepsis-related costs can exceed $34 million. A bet on a new approach to sepsis care paid off for OLOLRMC. Reflecting its confidence in IntelliSep's clinical and operational impact at scale, the system's leadership has expanded IntelliSep across four additional sites within FMOLHS. "As health systems face mounting pressures to deliver efficient, effective care, adopting this precise, rapid method will be key to saving lives and controlling costs," Dr. Thomas added. "Those who embrace this approach position themselves at the forefront of sepsis care innovation." About Cytovale®Cytovale is committed to improving patient care by pioneering early detection technologies that assess immune activation to accelerate the time it takes to get from triage to life-saving therapies. Cytovale's U.S. Food and Drug Administration-cleared rapid sepsis diagnostic, IntelliSep®, leverages machine learning and advanced microfluidics to provide Emergency Department clinicians with an objective and highly sensitive early detection tool for sepsis. IntelliSep measures the dysregulated immune system response to infection that would indicate sepsis and generates results in about eight minutes using a standard blood draw. Cytovale is based in San Francisco and venture-backed by Norwest Venture Partners, Sands Capital and Global Health Investment Corporation (GHIC). For more information, visit and follow Cytovale on LinkedIn and X. View original content to download multimedia: SOURCE Cytovale Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
